Glucotrack, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Glucotrack announced a 1-for-15 reverse stock split effective August 31, 2026, reducing outstanding shares from 11,972,157 to approximately 798,144 shares. The split aims to restore Nasdaq compliance (minimum $1.00 bid price requirement); the company must maintain that threshold through November 9, 2026 or face delisting. Stockholder ownership percentages unchanged except for fractional share rounding.
Why this rating
Reverse split signals financial distress (delisting risk) but is technical/tactical, not a business-model change. For a $5.4M market-cap company, this is material governance/compliance event with existential delisting threat — material relative to size.
Tradability signal
NO TRADE
No trade: price $0.32 is below our $0.5 floor — spreads at this level eat any edge.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $0.33 ▲ 0.59% | at our read · backfill $0.32 | +10 min · backfill $0.32 ▼ 0.77% | +30 min · backfill $0.32 ▼ 0.71% | +1 hr · backfill $0.31 ▼ 4.32% | +4 hrs · backfill $0.29 ▼ 11.17% |
The stock had already moved -0.58% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.